SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending after reporting quarterly results that beat analyst expectations, fueling massive investor optimism regarding its AI-driven turnaround and server processor demand. The community is actively discussing a significant short squeeze, with many retail investors highlighting their long-term conviction and celebrating the stock's surge to record highs.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging in after-hours trading, fueled by a sympathy rally following Intel's stronger-than-expected earnings and guidance which highlighted a major rebound in AI-driven data center CPU demand. The community is actively debating whether this momentum marks a sustainable phase of expansion or a blow-off top, with bullish investors pointing to the growing AI infrastructure cycle as justification for higher price targets while bears express concern over the stock's rapid valuation increase and overbought technical indicators.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The semiconductor sector's relentless rally has left investors heavily debating the viability of SOXS, as many are struggling with significant losses while the underlying index continues to hit new highs without a meaningful pullback. Community sentiment is deeply divided between those calling for an imminent, violent reversal and others warning that volatility decay makes this inverse, leveraged instrument a dangerous long-term hold.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently the focal point of intense community speculation and volatility as it continues a record-breaking rally, with investors debating whether this momentum represents a sustainable super-cycle or a classic blow-off top. The conversation is dominated by contrasting views on the sustainability of semiconductor demand, with many traders riding the parabolic momentum while others aggressively hedge with inverse funds in anticipation of a potential market reversal.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume as investors react to the company's confirmed commercial orders from Marvell Technology and its strategic shift to U.S.-based operations. The community is heavily focused on the company's emergence as a vital component in AI data center infrastructure, with traders debating whether this surge represents a sustainable valuation re-rating or a short-lived gamma squeeze triggered by heavy call option activity.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing intense volatility and community-driven buying pressure following a major legal victory where a jury awarded the company substantial damages against a rival for fraudulent bot usage. Investors are actively debating whether the stock will trigger a massive short squeeze given the potential for a billion-dollar judgment and limited float, leading to aggressive accumulation despite frequent trading halts.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is drawing massive community attention as it navigates a prolonged trading range, with investors closely watching its $5 trillion valuation while debating the stock's potential for a breakout against semiconductor peers like AMD and Intel. While retail sentiment remains deeply polarized between bullish long-term conviction and frustration over the stock's recent lack of momentum, the broader discussion is dominated by the narrative of AI infrastructure build-outs and the ongoing rotation of capital across the chip sector.

Dumb SEND IT

Community members are actively rallying behind $DSIT, viewing the current market cap as an early entry opportunity before the token potentially graduates on its bonding curve. Discussion is heavily focused on the developer's engagement through airdrops and a collective push to drive volume and increase holder counts.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to the ongoing rollout of its fibromyalgia treatment, Tonmya, with the community closely tracking prescription data and pharmacy benefit manager coverage expansions. While some investors express deep frustration over historical dilution and the potential for future reverse splits, others remain focused on the potential for long-term revenue growth as the company navigates this commercial launch phase.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing extreme volatility as investors grapple with a massive sell-off following a rapid price surge, sparking intense debate over whether the stock is undergoing a fundamental correction or setting up for another short squeeze. The community remains deeply divided, with bears pointing to the company's significant debt load and potential securities investigations as red flags, while some bulls are actively searching for signs of a technical rebound or renewed institutional buying interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Options Traders Betting on a Big Move in Nuvation Bio Stock?

Investors need to pay close attention to NUVB stock based on the movements in the options market lately. 

Nuvation Bio Announces IBTROZI (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026

Nuvation Bio Announces IBTROZI (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026 Nuvation Bio Announces IBTROZI (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at...

Nuvation Bio (NYSE:NUVB) Insider Kerry Wentworth Sells 36,750 Shares

Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) insider Kerry Wentworth sold 36,750 shares of the business's stock in a transaction dated Friday, April 17th. The shares were sold at an average price...

Insider Selling: Nuvation Bio (NYSE:NUVB) Insider Sells 50,000 Shares of Stock

Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) insider Dongfang Liu sold 50,000 shares of the business's stock in a transaction dated Friday, April 17th. The stock was sold at an average price of...

Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026

Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026 Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May...

Wedbush Reaffirms Outperform Rating for Nuvation Bio (NYSE:NUVB)

Wedbush reaffirmed an "outperform" rating and set a $11.00 price target on shares of Nuvation Bio in a research note on Thursday...

Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB)

Key Points200,000 Class A shares were sold for a transaction value of `$904,000 at around $4.52 per share on April 6, 2026...

Nuvation Bio (NYSE:NUVB) Insider Sells $904,000.00 in Stock

Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) insider Kerry Wentworth sold 200,000 shares of the firm's stock in a transaction dated Monday, April 6th. The stock was sold at an average price of...

Nuvation Bio (NYSE:NUVB) Insider Kerry Wentworth Sells 200,000 Shares

Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) insider Kerry Wentworth sold 200,000 shares of the business's stock in a transaction that occurred on Monday, April 6th. The shares were sold at an...

Nuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the ten brokerages that are currently covering the stock, Marketbeat Ratings reports...

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Current Price	$5.04
Prev Close	$5.12
Open	$5.13
Dividend Yield	0.00%
50-Day Moving Average	$4.86
Beta	1.54
Avg. Volume	5.15M
PE Ratio	-8.41

52-Week High	$9.75
52-Week Low	$1.57
Market Capitalization	$1.78B
EPS (Annual)	-$0.5991
Price to Book	5.57
Revenue Per Employee	$211,080.54

NUVB
Nuvation Bio Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NUVB News

NUVBNuvation Bio Inc - Ordinary Shares - Class A